Acorda Therapeutics, Inc. (ACOR): Price and Financial Metrics

ACOR POWR Grades

• Value is the dimension where ACOR ranks best; there it ranks ahead of 89.7% of US stocks.
• The strongest trend for ACOR is in Sentiment, which has been heading up over the past 99 days.
• ACOR's current lowest rank is in the Stability metric (where it is better than 11.21% of US stocks).

ACOR Stock Summary

• ACORDA THERAPEUTICS INC's market capitalization of $13,337,057 is ahead of only 5.78% of US-listed equities.
• With a one year PEG ratio of 0.22, ACORDA THERAPEUTICS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 3.12% of US stocks.
• ACOR's price/sales ratio is 0.11; that's higher than the P/S ratio of just 2.77% of US stocks.
• Stocks that are quantitatively similar to ACOR, based on their financial statements, market capitalization, and price volatility, are SLQT, NXTP, HAYW, ACB, and IDXG.
• Visit ACOR's SEC page to see the company's official filings. To visit the company's web site, go to www.acorda.com.

ACOR Valuation Summary

• In comparison to the median Healthcare stock, ACOR's EV/EBIT ratio is 524.24% lower, now standing at -28.
• Over the past 208 months, ACOR's EV/EBIT ratio has gone down 23.9.

Below are key valuation metrics over time for ACOR.

ACOR Growth Metrics

The 2 year price growth rate now stands at -84.38%.
• Its year over year net income to common stockholders growth rate is now at 24.93%.
• Its 4 year net income to common stockholders growth rate is now at -337.4%.

ACOR's revenue has moved down $27,834,000 over the prior 15 months.

The table below shows ACOR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	124.063	-26.75	-105.625
2022-06-30	122.008	-33.923	-118.842
2022-03-31	122.742	-28.097	-95.024
2021-12-31	129.071	-41.348	-103.954
2021-09-30	130.263	-43.14	-166.434
2021-06-30	151.897	-37.033	-132.016

ACOR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ACOR has a Quality Grade of C, ranking ahead of 72.56% of graded US stocks.
• ACOR's asset turnover comes in at 0.251 -- ranking 176th of 680 Pharmaceutical Products stocks.
• BDSI, INVA, and CALA are the stocks whose asset turnover ratios are most correlated with ACOR.

The table below shows ACOR's key quality metrics over time.